Novo Nordisk readies trial results for next-generation weight-loss drug
Danish company expects data to show that CagriSema cuts weight by 25 per cent in just over a year
Full Article
Novo Nordisk readies trial results for next-generation weight-loss drug
FT.com
0 shares
1 views